Cargando…
DDX3X alleviates doxorubicin‐induced cardiotoxicity by regulating Wnt/β‐catenin signaling pathway in an in vitro model
The life‐threatening adverse effects of doxorubicin (Dox) caused by its cardiotoxic properties limit its clinical application. DDX3X has been shown to participate in a variety of physiological processes, and it acts as a regulator of Wnt/β‐catenin signaling. However, the role of DDX3X in Dox‐induced...
Autores principales: | Feng, Dandan, Li, Jiang, Guo, Liang, Liu, Jing, Wang, Shaochen, Ma, Xiuyuan, Song, Yunxuan, Liu, Ju, Hao, Enkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539463/ https://www.ncbi.nlm.nih.gov/pubmed/35467791 http://dx.doi.org/10.1002/jbt.23077 |
Ejemplares similares
-
DDX3X deficiency alleviates LPS-induced H9c2 cardiomyocytes pyroptosis by suppressing activation of NLRP3 inflammasome
por: Feng, Dandan, et al.
Publicado: (2021) -
PKC-ζ Aggravates Doxorubicin-Induced Cardiotoxicity by Inhibiting Wnt/β-Catenin Signaling
por: Cao, Yan-Jun, et al.
Publicado: (2022) -
Yangxin granules alleviate doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis mediated by AKT/GSK3β/β-catenin signaling
por: Ren, Dezhi, et al.
Publicado: (2020) -
DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
por: Zhang, Tong, et al.
Publicado: (2018) -
Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27
por: Bernard, Yohann, et al.
Publicado: (2011)